Opening Story
FDA Approves New Indication for Tzield (teplizumab) in Pediatric Type 1 Diabetes
The FDA's recent accelerated approval of Tzield for certain pediatric patients represents a significant advancement in the management of recently diagnosed Stage 3 Type 1 Diabetes.
Read story